ARROWHEAD PHARMACEUTICALS, INC.
Financial highlights
| Metric | FY 09/30/25 | FY 09/30/24 | FY 09/30/23 | FY 09/30/22 | FY 09/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $829.4 | $3.6 | $240.7 | $243.2 | $138.3 |
| Operating income | $98.3 | -$601.1 | -$205.0 | -$178.5 | -$149.0 |
| Net income | -$1.6 | -$599.5 | -$205.3 | -$176.1 | -$140.8 |
| Cash Flow Statement | |||||
| Free cash flow | $156.9 | -$604.3 | -$330.6 | -$188.9 | $147.7 |
Shares outstanding 141.3M · Free float 91.4%
Annual filing data through FY ended September 30, 2025; float as of September 22, 2026.